By vgreene, 13 April, 2021 AstraZeneca University of Oxford Vaxzevria Covishield India AZD1222 ChAdOx1 S
By vgreene, 13 April, 2021 virus like particle vaccines self assembling multiprotein structures mimicking authentic native virus but lacking viral genome nonreplicative nonpathogenic
By vgreene, 13 April, 2021 subunit vaccines contain virus components rather than entire pathogen to minimize side effects often require adjuvant to elicit stronger immune response for long term immunity
By vgreene, 13 April, 2021 inactivated vaccines pathogenic agent killed by chemicals heat or radiation antigens from inactivated virus induce immune response
By vgreene, 13 April, 2021 recombinant vector based vaccines virus vectors genetically modified to include select proteins from pathogen of interest to induce immune response
